Principal Financial Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Buy
768,224
+22,868
+3% +$546K 0.01% 1014
2025
Q4
$19.9M Buy
745,356
+48,758
+7% +$1.17M 0.01% 902
2025
Q3
$14.9M Sell
696,598
-13,564
-2% -$321K 0.01% 1036
2025
Q2
$15.3M Sell
710,162
-44,586
-6% -$829K 0.01% 1008
2025
Q1
$12.5M Buy
754,748
+611,054
+425% +$11.1M 0.01% 1137
2024
Q4
$2.64M Buy
143,694
+14,143
+11% +$228K ﹤0.01% 1754
2024
Q3
$1.99M Buy
129,551
+52,340
+68% +$873K ﹤0.01% 1765
2024
Q2
$1.25M Sell
77,211
-7,585
-9% -$122K ﹤0.01% 1830
2024
Q1
$1.57M Sell
84,796
-11,418
-12% -$283K ﹤0.01% 1810
2023
Q4
$3.01M Buy
96,214
+18,074
+23% +$432K ﹤0.01% 1707
2023
Q3
$1.63M Buy
78,140
+14,958
+24% +$406K ﹤0.01% 1793
2023
Q2
$1.51M Sell
63,182
-3,551
-5% -$78.9K ﹤0.01% 1793
2023
Q1
$1.26M Sell
66,733
-8,240
-11% -$157K ﹤0.01% 1827
2022
Q4
$1.19M Buy
74,973
+8,875
+13% +$139K ﹤0.01% 1836
2022
Q3
$1.08M Sell
66,098
-52,305
-44% -$847K ﹤0.01% 1829
2022
Q2
$1.67M Buy
118,403
+78,054
+193% +$1.46M ﹤0.01% 1839
2022
Q1
$977K Buy
40,349
+884
+2% +$21.4K ﹤0.01% 1977
2021
Q4
$921K Sell
39,465
-18,378
-32% -$370K ﹤0.01% 2003
2021
Q3
$961K Buy
57,843
+1,759
+3% +$33.9K ﹤0.01% 2010
2021
Q2
$1.37M Buy
56,084
+7,893
+16% +$178K ﹤0.01% 1982
2021
Q1
$1.24M Buy
48,191
+2,111
+5% +$92.9K ﹤0.01% 1948
2020
Q4
$2.46M Sell
46,080
-646
-1% -$32.1K ﹤0.01% 1763
2020
Q3
$1.93M Sell
46,726
-9,859
-17% -$426K ﹤0.01% 1745
2020
Q2
$2.74M Sell
56,585
-9,099
-14% -$437K ﹤0.01% 1622
2020
Q1
$2.77M Buy
65,684
+2,365
+4% +$97.4K ﹤0.01% 1499
2019
Q4
$2.71M Sell
63,319
-30,646
-33% -$1.33M ﹤0.01% 1669
2019
Q3
$3.38M Buy
93,965
+8,378
+10% +$254K ﹤0.01% 1623
2019
Q2
$2.29M Buy
85,587
+52,869
+162% +$1.35M ﹤0.01% 1706
2019
Q1
$879K Buy
32,718
+1,667
+5% +$38.9K ﹤0.01% 1849
2018
Q4
$502K Sell
31,051
-7,003
-18% -$136K ﹤0.01% 1919
2018
Q3
$790K Buy
38,054
+5,057
+15% +$79.6K ﹤0.01% 1885
2018
Q2
$504K Sell
32,997
-1,588
-5% -$28.3K ﹤0.01% 1964
2018
Q1
$777K Buy
34,585
+1,732
+5% +$48K ﹤0.01% 1868
2017
Q4
$989K Buy
32,853
+19,524
+146% +$624K ﹤0.01% 1841
2017
Q3
$502K Sell
13,329
-3,481
-21% -$113K ﹤0.01% 1928
2017
Q2
$469K Buy
16,810
+579
+4% +$17.3K ﹤0.01% 1959
2017
Q1
$558K Sell
16,231
-1,092
-6% -$38.5K ﹤0.01% 1907
2016
Q4
$500K Sell
17,323
-2,722
-14% -$72K ﹤0.01% 1925
2016
Q3
$638K Buy
20,045
+1,032
+5% +$35K ﹤0.01% 1826
2016
Q2
$617K Buy
19,013
+4,170
+28% +$140K ﹤0.01% 1818
2016
Q1
$415K Buy
14,843
+1,137
+8% +$24.8K ﹤0.01% 1873
2015
Q4
$489K Hold
13,706
﹤0.01% 1861
2015
Q3
$453K Buy
13,706
+2,634
+24% +$110K ﹤0.01% 1880
2015
Q2
$464K Sell
11,072
-496
-4% -$19.2K ﹤0.01% 1883
2015
Q1
$377K Sell
11,568
-148
-1% -$5.09K ﹤0.01% 1872
2014
Q4
$372K Sell
11,716
-1,767
-13% -$50.1K ﹤0.01% 1900
2014
Q3
$334K Hold
13,483
﹤0.01% 1894
2014
Q2
$305K Sell
13,483
-4,709
-26% -$98.3K ﹤0.01% 1960
2014
Q1
$443K Sell
18,192
-2,458
-12% -$62.2K ﹤0.01% 1887
2013
Q4
$516K Hold
20,650
﹤0.01% 1878
2013
Q3
$567K Sell
20,650
-1,353
-6% -$28.3K ﹤0.01% 1832
2013
Q2
$399K Buy
+22,003
New +$303K ﹤0.01% 1871

Other funds holding ACAD